000 01690cas  2200397zi 4500
0019.911317
003CaOODSP
00520221107182328
006m     o  d f      
007cr cn|||||||||
008220517c20229999oncqr p o    f0###a0eng|d
022 |a2816-6396
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aH167-5E-PDF
1101 |aCanada.|bPharmaceutical Drugs Directorate, |eauthor, |eissuing body.
222 0|aDrug submission performance quarterly report |b(Canada. Pharmaceutical Drugs Directorate)
24510|aDrug submission performance quarterly report.
24613|aPDD quarterly drug submission performance report
264 1|aOttawa, Ontario : |bHealth Canada = Santé Canada, |c2022-
310 |aQuarterly
336 |atext|2rdacontent
337 |acomputer|2rdamedia
338 |aonline resource|2rdacarrier
3621 |aBegan with: January to March 2022.
500 |aIssued also in French under title: Rapport trimestriel du rendement des présentations de drogue.
588 |aDescription based on: January to March 2022.
588 |aLatest issue consulted: January to March 2022.
61010|aCanada. |bPharmaceutical Drugs Directorate|vPeriodicals.
650 0|aPharmaceutical policy|zCanada|vPeriodicals.
650 0|aDrugs|xLaw and legislation|zCanada|vPeriodicals.
650 0|aDrugs|xTesting|xStandards|vPeriodicals.
650 0|aDrugs|xTesting|xGovernment policy|zCanada|vPeriodicals.
655 7|aPeriodicals|2lcgft
77508|tRapport trimestriel du rendement des présentations de drogue.|w(CaOODSP)9.911318
78000|tDrug submission performance quarterly report ... |w(CaOODSP)9.851914